Skip to main content
. 2011 Oct 1;7(10):1060–1065. doi: 10.4161/hv.7.10.16480

Figure 1.

Figure 1

Reverse cumulative distribution of varicella zoster virus (VZV) antibody titers (log scale) before vaccination and 28–35 d following vaccination with ZOSTAVAX at minimum-release specification approaching expiry potency (per-protocol set; n = 92). BS1, blood sample 1 (before vaccination); BS2, blood sample 2 (28–35 d following vaccination).